Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients undergoing autologous peripheral blood stem cell transplant (PBSC) for relapsed/refractory Hodgkin's disease, non-Hodgkin's lymphoma, or patients with myeloma. All patients must meet criteria for transplantation.~Exclusion Criteria:~* Patients with active, invasive/systemic fungal infection.~* Patients who are pregnant or lactating females.~* Patients with active CNS malignant disease or life expectancy limited by diseases other than the disease for which the patient is being transplanted.~* Also, patients cannot have known hypersensitivity to either G-CSF or GM-CSF.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Abdomen (Type: ACTIVE_COMPARATOR): These subjects will have their cytokine injections administered only to their abdomen.
- Extremities (Type: ACTIVE_COMPARATOR): The extremity arm will have their injections administered to their upper and/or lower extremities.

Based on this trial design, predict the completion outcome and termination type (if applicable).